| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1955 | Endosidin1 | Natural vesicle trafficking inhibitor |
|
| DCC1956 | Endosidin3 | Specific inhibitor of trafficking pathways, disrupting recycling at the PM via interference with ROP6/RIC1 signalling |
|
| DCC1957 | Endosidin4 | Novel inhibitor of eukaryotic ARF-GEFs (ADP-ribosylation factor guanine nucleotide exchange factors) |
|
| DCC1959 | Endosidin7 | Specific inhibitor for plant callose deposition during cytokinesis without affectting endomembrane trafficking during interphase or cytoskeletal organization |
|
| DCC1960 | Endosidin8.0 | Novel modulator of the PIN1 accumulation, selectively modifying PIN1 basal plasma membrane targeting in Arabidopsis with minimal effects on apical plasma membrane proteins |
|
| DCC1961 | Endosidin8.1 | Novel modulator of the PIN1 accumulation, selectively modifying PIN1 basal plasma membrane targeting in Arabidopsis with minimal effects on apical plasma membrane proteins |
|
| DCC1962 | Eniporide Hydrochloride | Sodium/hydrogen exchange inhibitor |
|
| DCC1963 | Enl-in-7 | Novel potent inhibitor of eleven-nineteen leukemia (ENL) protein, selectively targeting the ENL YEATS domain |
|
| DCC1964 | Enmd-2076 Tartrate | Novel oral inhibitor of angiogenic and proliferation kinases, having activity in recurrent, platinum resistant ovarian cancer |
|
| DCC1965 | Enpp1 Inhibitor 43 | Novel potent inhibitor of ecto-nucleotide pyrophosphatase/phosphodiesterases 1 (ENPP1 or NPP1), showing good in vitro potency, stability in SGF/SIF/PBS, selectivity, ADME properties and pharmacokinetic profile and finally potent anti-tumor response in viv |
|
| DCC1966 | Enprostil | PGE2 analog, inhibiting gastric acid secretion |
|
| DCC1967 | Ent Naxagolide Hydrochloride | Dopamine D2-receptor agonist for the treatment of extrapyramidal disorders, also being an antiparkinson agent |
|
| DCC1968 | Entasobulin Featured | Entasobulin is a β-tubulin polymerization inhibitor with potential anticancer activity. |
|
| DCC1969 | Entpd5-in-1a | Novel inhibitor of Ectonucleoside Triphosphate Diphosphohydrolase 5 (ENTPD5) |
|
| DCC1970 | Entpd5-in-2f | Novel inhibitor of Ectonucleoside Triphosphate Diphosphohydrolase 5 (ENTPD5) |
|
| DCC1971 | Ent-verticilide | Unnatural verticilide enantiomer, inhibiting type 2 ryanodine receptor-mediated calcium leak and being antiarrhythmic. |
|
| DCC1972 | Ep-7041 | Novel, potent, and selective Factor XIa inhibitor |
|
| DCC1973 | Epc-k1 | Vitamin E derivative, suppressing inflammation during hepatic ischemia-reperfusion injury and exerting hepatoprotective effects |
|
| DCC1974 | Epetraborole R-mandelate | Novel potent and selective leucyl-tRNA synthetase inhibitor |
|
| DCC1975 | Epha2-agonist-27 | Novel agonist of EphA2 receptor tyrosine kinase |
|
| DCC1976 | Ephb1-in-10 | Potent and selective covalent inhibitor of receptor tyrosine kinase EphB1 |
|
| DCC1977 | Ephb3-in-10 | Novel clickable potent and specific inhibitor of EphB3 |
|
| DCC1978 | Ephb3-in-9 | The first potent and specific inhibitor of a single Eph isoform EphB3 |
|
| DCC1979 | Epi-0023 | Novel selrctive SETD8 inhibitor without inhibiting G9a, SETD7, RmtA, and PRMT1 |
|
| DCC1980 | Epibestatin Hydrochloride | Novel stabilizer of 14-3-3 PPIs, Diastereoepimer of aminopeptidase inhibitor bestatin |
|
| DCC1981 | Epinastine Hydrobromide | Second-generation antihistamine and mast cell stabilizer, being highly selective for the H1 receptor |
|
| DCC1982 | Epi-nocardicin G | The precursor of the nocardicins |
|
| DCC1983 | Eprazinone | Mucolytic and bronchospasm relieving agent |
|
| DCC1984 | Eps-in-1 | Novel inhibitor of extracellular polymeric substances (EPS) |
|
| DCC1985 | Eptapirone Fumarate | Potent, selective, high efficacy 5-HT1A receptor agonist |
|
